Literature DB >> 17143816

Patients with previously treated tuberculosis no longer neglected.

Matteo Zignol1, Abigail Wright, Ernesto Jaramillo, Paul Nunn, Mario C Raviglione.   

Abstract

Over the past decade, global and national tuberculosis (TB)-control programs, challenged with limited resources, have had to prioritize interventions to maximize impact. For this reason, patients with newly diagnosed cases of TB received more attention than did patients with a previous history of treatment. The recently launched STOP TB Strategy and Global Plan to STOP TB 2006-2015 now promote proper diagnosis and treatment of TB for all patients, without distinction of smear status, drug susceptibility, sex, or age, including all patients with a history of previous treatment. Previously treated patients are difficult to re-treat and represent an important source of disease transmission, as well as a serious threat to TB control worldwide, because of their higher rate of drug resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143816     DOI: 10.1086/509328

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  18 in total

1.  False-Positive Xpert MTB/RIF Results in Retested Patients with Previous Tuberculosis: Frequency, Profile, and Prospective Clinical Outcomes.

Authors:  Grant Theron; Rouxjeane Venter; Liezel Smith; Aliasgar Esmail; Philippa Randall; Vishesh Sood; Suzette Oelfese; Greg Calligaro; Robin Warren; Keertan Dheda
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

2.  6-Oxo and 6-thio purine analogs as antimycobacterial agents.

Authors:  Ashish K Pathak; Vibha Pathak; Lainne E Seitz; William J Suling; Robert C Reynolds
Journal:  Bioorg Med Chem       Date:  2013-02-04       Impact factor: 3.641

3.  Tuberculosis diagnosed in a rural setting in Angola. Accuracy of follow-up sputum smears to predict outcome.

Authors:  Teresa López; Milagros Moreno; Fernando Salvador; Adriano Zacarías; Rosa de Carvalho; Estevao Tomás; Gabriel Estevao; Arlette Nindia Eugenio; Joaquin Burgos; Elena Sulleiro; Israel Molina; Vicenç Falcó
Journal:  Pathog Glob Health       Date:  2013-01       Impact factor: 2.894

4.  Treatment and recurrence on re-treatment tuberculosis patients: a randomized clinical trial and 7-year perspective cohort study in China.

Authors:  Jian Du; Le Zhang; Yan Ma; X-Y Chen; Q-P Ge; X-Z Tian; Weiwei Gao; Zhongwei Jia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-05       Impact factor: 3.267

5.  Drug resistance pattern and associated risk factors of tuberculosis patients in the central province of Iran.

Authors:  Aliasghar Farazi; Masoomeh Sofian; Nader Zarrinfar; Fatemeh Katebi; Seyed Davood Hoseini; Roohollah Keshavarz
Journal:  Caspian J Intern Med       Date:  2013

6.  Predictors and short-term outcomes of recurrent pulmonary tuberculosis, Uganda: a cohort study.

Authors:  Nelson Kalema; Christina Lindan; Dave Glidden; Samuel D Yoo; Achilles Katamba; Andama Alfred; Winceslaus Katagira; Patrick Byanyima; Emmanuel Musisi; Sylvia Kaswabuli; Sanyu Ingvar; Josephine Zawedde; Christina Yoon; Irene Ayakaka; J Lucian Davis; Laurence Huang; William Worodria; Adithya Cattamanchi
Journal:  S Afr Respir J       Date:  2017

7.  Epidemiology of anti-tuberculosis drug resistance in a Chinese population: current situation and challenges ahead.

Authors:  Yan Shao; Dandan Yang; Weiguo Xu; Wei Lu; Honghuan Song; Yaoyao Dai; Hongbing Shen; Jianming Wang
Journal:  BMC Public Health       Date:  2011-02-17       Impact factor: 3.295

8.  Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing.

Authors:  Matteo Zignol; Wayne van Gemert; Dennis Falzon; Ernesto Jaramillo; Léopold Blanc; Mario Raviglione
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

9.  Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco.

Authors:  Kelly E Dooley; Ouafae Lahlou; Iraqi Ghali; Janine Knudsen; My Driss Elmessaoudi; Imad Cherkaoui; Rajae El Aouad
Journal:  BMC Public Health       Date:  2011-02-28       Impact factor: 3.295

10.  Predictors of death among patients who completed tuberculosis treatment: a population-based cohort study.

Authors:  Juan-Pablo Millet; Angels Orcau; Cristina Rius; Marti Casals; Patricia Garcia de Olalla; Antonio Moreno; Jeanne L Nelson; Joan A Caylà
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.